Ethionamide

Tuberculosis

Volumn 88, Issue 2, 2008, Pages 106-108

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AETINA; CYCLOSERINE; ETHIONAMIDE; ISONIAZID; PROTIONAMIDE; PYRAZINAMIDE; RIFAMPICIN; THIOACETAZONE; TIO MID; TIOCARLIDE;

ABDOMINAL PAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; DIARRHEA; DRUG ACTIVATION; DRUG ACTIVITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG SOLUBILITY; DRUG TARGETING; DRUG TOLERABILITY; DRUG WITHDRAWAL; GENE EXPRESSION; GENE MUTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER TOXICITY; MACROPHAGE; MONOTHERAPY; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NAUSEA; NONHUMAN; PRIORITY JOURNAL; RAT; REPRESSOR GENE; REVIEW; SALIVATION; SIDE EFFECT; SINGLE DRUG DOSE; STOMATITIS; TASTE DISORDER; TERATOGENESIS; TUBERCULOSIS; VOMITING; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; ANTITUBERCULAR AGENTS; ETHIONAMIDE; HUMANS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 43249101083     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-9792(08)70009-X     Document Type: Review

References (16)

1. Banerjee A., et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263 (1994) 227-230
2. Johnsson K., et al. Studies on the mechanism of action of isoniazid and ethionamide in the chemotherapy of tuberculosis. J Am Chem Soc 117 (1995) 5009-5010
3. Baulard A., et al. Activation of the pro-drug ethionamide is regulated in mycobacteria. J Biol Chem 275 (2000) 28326-28331
4. Engohang-Ndong J., et al. EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator. Mol Microbiol 51 (2004) 175-188
5. DeBarber A., et al. Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis. Proc Natl Acad Sci USA 97 (2000) 9677-9682
6. Wang F., et al. Mechanism of thioamide drug action against tuberculosis and leprosy. J Exp Med 204 (2007) 73-78
7. Di Perri G., and Bonora S. Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?. J Antimicrob Chemother 54 (2004) 593-602
8. Rastogi N., et al. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Curr Microbiol 33 (1996) 167-175
9. Fajardo T., et al. A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy. Am J Trop Med Hyg 74 (2006) 457-461
10. Jagannath C., et al. Activities of poloxamer CRL8131 against Mycobacterium tuberculosis in vitro and in vivo. Antimicrob Agents Chemother 39 (1995) 1349-1354
11. Cynamon M., and Sklaney M. Gatifloxacin and ethionamide as the foundation for therapy of tuberculosis. Antimicrob Agents Chemother 47 (2003) 2442-2444
12. Klemens S., et al. Therapy of multidrug-resistant tuberculosis: lessons from studies with mice. Antimicrob Agents Chemother 37 (1993) 2344-2347
13. Zhu M., et al. Population pharmacokinetics of ethionamide in patients with tuberculosis. Tuberculosis 82 (2002) 91-96
14. Auclair B., et al. Pharmacokinetics of ethionamide administered under fasting conditions or with orange juice, food, or antacids. Antimicrob Agents Chemother 45 (2001) 810-814
15. Chan E., et al. Pyrazinamide, ethambutol, ethionamide, and aminoglycosides. In: Rom W., and Garay S. (Eds). Tuberculosis. 2nd edition (2003), Lippincott Williams & Wilkins, Philadelphia, PA 780-781
16. Drucker D., et al. Ethionamide-induced goitrous hypothyroidism. Ann Intern Med 100 (1984) 837-839